Chuanmin Chu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
- Kidney Stones and Urolithiasis Treatments
- Renal cell carcinoma treatment
Papers in
-
- Epigenetics and DNA Methylation 4
- Kruppel-like factors research 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Ferroptosis and cancer prognosis 4
- Renal cell carcinoma treatment 3
- Co-authors
- Xiuwu Pan (14 shared papers)Sishun Gan (11 shared papers)Jianqing Ye (9 shared papers)Fajun Qu (9 shared papers)Xingang Cui (3 shared papers)Qiwei Yang (4 shared papers)Xingang Cui (7 shared papers)Yi Gao (2 shared papers)
- Journals
- Journal of drug targeting (2 papers)Cell & Bioscience (1 paper)International Journal of Biological Macromolecules (1 paper)Scientific Reports (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chuanmin Chu
22 papers receiving 489 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 150
- Pulmonary and Respiratory Medicine 163
- Immunology 85
- Molecular Biology 251
- Oncology 97
Countries citing papers authored by Chuanmin Chu
This map shows the geographic impact of Chuanmin Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanmin Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanmin Chu more than expected).
Fields of papers citing papers by Chuanmin Chu
This network shows the impact of papers produced by Chuanmin Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanmin Chu. The network helps show where Chuanmin Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chuanmin Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 85 | |
| 2 | 2018 | 50 | |
| 3 | 2018 | 47 | |
| 4 | 2020 | 43 | |
| 5 | 2017 | 37 | |
| 6 | 2020 | 31 | |
| 7 | 2021 | 28 | |
| 8 | 2018 | 25 | |
| 9 | 2016 | 23 | |
| 10 | Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis | 2020 | 20 |
| 11 | 2017 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2018 | 17 | |
| 14 | 2019 | 17 | |
| 15 | 2022 | 10 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2021 | 3 |
About Chuanmin Chu
Chuanmin Chu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Cell Biology, having authored 25 papers that have together received 492 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers), interferon and immune responses (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Kruppel-like factors research (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cancer Research (150 citations), Pulmonary and Respiratory Medicine (163 citations), Immunology (85 citations), Molecular Biology (251 citations) and Oncology (97 citations). Chuanmin Chu has collaborated with scholars based in China and United States. Frequent co-authors include Xiuwu Pan, Sishun Gan, Jianqing Ye, Fajun Qu, Xingang Cui, Qiwei Yang, Xingang Cui, Yi Gao, Yinghao Sun and Xiaopeng Duan. Their work appears in journals such as Journal of drug targeting, Cell & Bioscience, International Journal of Biological Macromolecules, Scientific Reports and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.